(Press-News.org) WASHINGTON, D.C. (March 8 2011) -- Researchers at the Instituto de Medicina Molecular in Lisbon, Portugal and the Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, are making major strides toward understanding the life cycle of flaviviruses, which include some of the most virulent human pathogens: yellow fever virus, Dengue virus, and the West Nile Virus, among others.
Today, at the 55th Annual Meeting of the Biophysical Society in Baltimore, MD, members of the team will report on studies using dengue virus as a model to elucidate the molecular details of the flavivirus life cycle -- work that may lead to new ways to fight Dengue virus infections, for which there are still no treatments and no effective preventative vaccines.
Dengue virus is one of the major causes of viral hemorrhagic fever worldwide, says Ivo Martins, a postdoctoral researcher in the group. About 40 percent of the world's population live in areas where this virus is transmitted. The World Health Organization estimates that 50-100 million people worldwide are infected with Dengue each year, and some 22,000 people die rom the virus -- mostly children.
Dengue virus is transmitted by the Aedes aegypti and Aedes albopictus mosquitoes, which are now found throughout the world, including in temperate regions such as the United States and France, where, in 2010, there were several cases of locally transmitted Dengue -- a disease that has been virtually unknown in these countries before.
"The burden that dengue infection (and other flaviviruses) poses on the economy and health systems of affected countries is considerable," says Martins. "Finding a dengue treatment, besides the obvious human health benefits, would thus benefit the economy in those countries immensely."
In Baltimore, Martins will discuss the group's use of biophysical techniques (nuclear magnetic resonance) combined with bioinformatics tools (genome sequence analysis) to elucidate the molecular details of interactions the Dengue virus capsid protein must make in order for it to replicate. In particular, the virus capsid protein must interact with intracellular lipid droplets in order for viral replication to be successful.
###
The presentation, "CHARACTERIZATION OF THE INTERACTION OF THE DENGUE VIRUS CAPSID PROTEIN WITH LIPID DROPLETS" by Ivo C. Martins et al is at 1:45 p.m. on Tuesday, March 8, 2011 in Hall C of the Baltimore Convention Center. ABSTRACT: http://tinyurl.com/688en3a
NOTE TO EDITORS: An image is available to accompany this story. Visit URL
IMAGE CAPTION: Figure 1. Studying the dengue virus capsid protein. Gathering several biophysical techniques allows us to have a complete picture of the role of Dengue virus capsid protein (DVCP) in viral RNA encapsidation and assembly in the context of its interaction with lipid membranes.
IMAGE CREDIT: Reporters may freely reproduce this image so long as they include the following credit: Image courtesy of Ivo C. Martins/Institute of Molecular Medicine (IMM), Lisbon, Portugal.
This work was funded by Fundação Calouste Gulbenkian (FCG), Portugal; Fundação para a Ciência e Tecnologia (FCT), Portugal; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil; FP7 – International Staff Exchange Scheme (FP7-IRSES), European Union; and FP7 – Marie Curie International Outgoing Fellowship (FP7-MCIOF), European Union.
MORE MEETING INFORMATION
Each year, the Biophysical Society Annual Meeting brings together more than 6,000 scientists and hosts more than 4,000 poster presentations, 200 exhibits, and more than 20 symposia. The largest meeting of its type in the world, the Biophysical Society Annual Meeting retains its small-meeting flavor through its subgroup meetings, platform sessions, social activities, and committee programs.
QUICK LINKS
Meeting Home Page:
http://www.biophysics.org/2011meeting
General Meeting Information:
http://www.biophysics.org/GeneralInfo/Overview/tabid/2062/Default.aspx
Search abstracts:
http://www.abstractsonline.com/plan/start.aspx?mkey={FEA830A5-24AD-47F3-8E61-FCA29F5FEF34}
PRESS REGISTRATION
The Biophysical Society invites credentialed journalists, freelance reporters working on assignment, and public information officers to attend its Annual Meeting for free. For more information on registering as a member of the press, please contact Ellen Weiss at eweiss@biophysics.org or 240-290-5606. Also see: http://www.biophysics.org/Registration/Press/tabid/2148/Default.aspx
ABOUT THE BIOPHYSICAL SOCIETY
The Biophysical Society, founded in 1956, is a professional, scientific society established to encourage development and dissemination of knowledge in biophysics. The society promotes growth in this expanding field through its annual meeting, monthly journal, and committee and outreach activities. Its over 9,000 members are located throughout the U.S. and the world, where they teach and conduct research in colleges, universities, laboratories, government agencies, and industry. For more information on the society or the 2011 Annual Meeting, visit www.biophysics.org
END
WASHINGTON, D.C. (March 8 2011) -- Viruses can penetrate every part of the body, making them potentially good tools for gene therapy or drug delivery. But with our immune system primed to seek and destroy these foreign invaders, delivering therapies with viruses is currently inefficient and can pose a significant danger to patients.
Now scientists at the University of Pennsylvania have engineered a virus with potential to solve this problem. They describe the new virus today at the 55th Annual Biophysical Society Meeting in Baltimore, MD.
"We would like to find a way ...
WASHINGTON, D.C. (March 8, 2011) -- Scientists in Israel and California have developed an instrument for rapidly analyzing molecular interactions that take place viruses and the cells they infect. By helping to identify interactions between proteins made by viruses like HIV and hepatitis and proteins made by the human cells these viruses infect, the device may help scientists develop new ways of disrupting these interactions and find new drugs for treating those infections.
According to Doron Gerber, a professor at Bar Ilan University in Ramat Gan, the PING system (Protein ...
It's all too familiar: researchers announce the discovery of a new drug that eradicates disease in animals. Then, a few years later, the drug bombs in human trials. In the latest issue of the journal PLoS Medicine, ethics experts Jonathan Kimmelman, associate professor at McGill's Biomedical Ethics Unit and Department of Social Studies of Medicine, and Alex John London, associate professor of philosophy at Carnegie Mellon University, argue that this pattern of boom and bust may be related to the way researchers predict outcomes of their work in early stages of drug development.
"We ...
Economic growth in India has no automatic connection to reducing undernutrition in Indian children and so further reductions in the prevalence of childhood undernutrition are likely to depend on direct investments in health and health-related programs. These are the conclusions of a large study by researchers at the Schools of Public Health at University of Michigan and Harvard University, that is published in this week's PLoS Medicine.
Malavika Subramanyam, S V Subramanian and colleagues collected data from the National Family Health Surveys conducted in India in 1992-93 ...
In this week's PLoS Medicine, Jonathan Kimmelman from McGill University in Montreal, Canada and Alex London from Carnegie Mellon University in Pittsburgh, USA argue that ethical reviewers and decision-makers pay insufficient attention to threats to validity in pre-clinical studies and consult too narrow a set of evidence. They propose a better way for ethical and scientific decision makers to assess early phase studies: first, to attend to reporting and methodological quality in preclinical experiments that support claims of internal, construct, and external validity; and ...
WASHINGTON, DC, March 3, 2011 — Communication technologies that help people stay connected to the workplace are often seen as solutions to balancing work and family life. However, a new study in the March issue of the Journal of Health and Social Behavior suggests there may be a "dark side" to the use of these technologies for workers' health—and these effects seem to differ for women and men.
Using data from a national survey of American workers, University of Toronto researchers asked study participants how often they were contacted outside the workplace by phone, e-mail, ...
Hidden financial conflicts-of-interest are sneaking into published drug research through the back door, warns an international team of investigators, led by researchers from the Jewish General Hospital's Lady Davis Institute for Medical Research and McGill University in Montreal.
More and more, policy decisions and what medications doctors prescribe for their patients are being driven by large "studies of studies," called meta-analyses, which statistically combine results from many individual drug trials.
Led by Dr. Brett Thombs and McGill graduate student Michelle ...
In a study that included more than 120,000 adults who were treated for trauma, 16 percent of these patients died within 3 years of their injury, compared to an expected population mortality rate of about 6 percent, according to a study in the March 9 issue of JAMA. The researchers also found that trauma patients who were discharged to a skilled nursing facility had a significantly increased risk of death compared with patients discharged home without assistance.
Trauma can lead to significant illness or death. "To date, there have been few large studies evaluating long-term ...
Information concerning funding and author conflicts of interest disclosed in the original reports of randomized controlled trials is rarely disclosed when these data are combined in meta-analyses, according to an article in the March 9 issue of JAMA.
"Conflicts of interest (COIs) related to the funding of biomedical research by pharmaceutical companies and financial relationships between researchers and pharmaceutical companies have come under increased scrutiny in recent years. COIs may influence the framing of research questions, study design, data analysis, interpretation ...
Study participants who viewed a brief hands-only cardiopulmonary resuscitation (CPR) video were more likely to attempt CPR, and perform better quality CPR in an emergency than participants who did not view the short videos, according to research reported in Circulation: Cardiovascular Quality and Outcomes.
Each year, almost 300,000 people suffer out-of-hospital cardiac arrests in the United States. Survival rates from these events tend to be extremely low. However, research has shown that bystander CPR can double — even triple — survival from out-of-hospital cardiac ...
